Broadly neutralizing antibodies: "The next thing" to treat children with HIV?

Maud Mavigner1,2,3, Ann Chahroudi1,2,3

  • 1Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA.

PubMed

Insights

Monthly infusions of two neutralizing antibodies kept HIV suppressed in about half of children who had early antiretroviral treatment.

Area of Science:

  • Immunology
  • Virology
  • Pediatric Infectious Diseases

Background:

  • Early antiretroviral treatment (ART) is crucial for managing pediatric HIV.
  • Long-term HIV suppression strategies beyond daily ART are needed.

Purpose of the Study:

  • To evaluate the efficacy of monthly infusions of two neutralizing antibodies for maintaining HIV suppression in children previously treated early with ART.

Main Methods:

  • A study involving children who received early antiretroviral treatment.
  • Monthly administration of two specific neutralizing antibodies.

Main Results:

  • HIV suppression was maintained in nearly 50% of the children during the study period.
  • This indicates a potential alternative or adjunctive approach to long-term HIV management.

Conclusions:

  • Monthly neutralizing antibody treatment can maintain HIV suppression in a significant proportion of children with a history of early ART.
  • Further research is warranted to optimize antibody-based strategies for pediatric HIV remission.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Cross-reactivity00:42

Cross-reactivity

Overview
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...